Deep knowledge on 
 small-molecule drugs and 
 the 100,000 global patents 
 covering them 

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

How are People Using DrugPatentWatch?

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: flunisolide

« Back to Dashboard
Flunisolide is the generic ingredient in five branded drugs marketed by Roche Palo, Meda Pharms Inc, Apotex Inc, Bausch And Lomb, Hi Tech Pharma Co, Ivax Res, and Teva Branded Pharm, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has twelve patent family members in eleven countries.

There are twelve drug master file entries for flunisolide. One supplier is listed for this compound.

Summary for Generic Name: flunisolide

Tradenames:5
Patents:1
Applicants:7
NDAs:7
Drug Master File Entries: see list12
Suppliers / Packaging: see list2
Therapeutic Class:Respiratory Tract Agents

Pharmacology for Ingredient: flunisolide

Clinical Trials for: flunisolide

Flunisolide HFA in Children With Small Airway Disease
Status: Recruiting Condition: Asthma

Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire (EARNS-Q)
Status: Completed Condition: Rhinitis, Allergic, Perennial

Mentored Patient-Oriented Research Career Development Award
Status: Recruiting Condition: Asthma; Distal Lung Inflammation

Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy
Status: Completed Condition: Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Res
NASALIDE
flunisolide
SPRAY, METERED;NASAL018148-001Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
Meda Pharms Inc
AEROSPAN HFA
flunisolide
AEROSOL, METERED;INHALATION021247-001Jan 27, 2006RXYes<disabled><disabled>
Bausch And Lomb
FLUNISOLIDE
flunisolide
SPRAY, METERED;NASAL074805-001Feb 20, 2002RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: flunisolide

These historical archives are available as an add-on to one-year subscriptions

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo
AEROBID
flunisolide
AEROSOL, METERED;INHALATION018340-001Aug 17, 19844,933,168<disabled>
Teva Branded Pharm
NASAREL
flunisolide
SPRAY, METERED;NASAL020409-001Mar 8, 19954,933,168<disabled>
Teva Branded Pharm
NASAREL
flunisolide
SPRAY, METERED;NASAL020409-001Mar 8, 19954,782,047<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: flunisolide

Country Document Number Publication Date
World Intellectual Property Organization (WIPO)9517195Jun 29, 1995
Australia1098695Jul 10, 1995
European Patent Office0735884Oct 09, 1996
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2016 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc